Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
28 Results Found
AHA Statement to House E&C Health Subcommittee on Lowering Health Care Costs for All Americans
AHA Statement before the House Committee on Energy and Commerce
Health Subcommittee on “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain”
House Subcommittee to Host Feb. 11 Hearing with Suppliers as Part of Series Focused on Health Care Affordability
The issue of affordability, including health care affordability, is front and center this year and will be part of this year's congressional and administration discussions, as well as the mid-term elections.
Fact Sheet: Impact of Tariffs on Health Care Equipment
Medical supply expenses collectively accounted for $146.9 billion in 2023, an increase of $6.6 billion over 2022, according to data from Strata Decision Technology. The tariffs on Chinese made semiconductors solar cells, syringes and needles will increase to 50% from the 25% they are at now.
AHA Responds to Department of Commerce’s RFI on PPE and Medical Equipment
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on personal protective equipment (PPE), medical consumables and medical equipment.
AHA Statement of Record for Senate Special Committee on Aging Hearing on Pharmaceutical and Medical Supply Chains
The American Hospital Association statement for the record to the Senate Special Committee on Aging hearing “Bad Medicine: Closing Loopholes that Kill American Patients.”
AHA Statement to House Energy & Commerce Subcommittee on Health Hearing for June 11, 2025
AHA statement for the record to the Committee on Energy and Commerce Health Subcommittee hearing “Made in America: Strengthening Domestic Manufacturing and the Health Care Supply Chain.”
AHA Senate Statement on Trade in Critical Supply Chains
AHA statement for the record to the Senate Committee on Finance regarding the importance of trade in critical supply chains.
AHA Urges Administration to Grant Exceptions for Current and Proposed Tariffs for Medications and Medical Supplies
The AHA late yesterday told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital medications and essential health care devices.
AHA Comments on Commerce Department Investigation of Pharmaceutical Imports
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on pharmaceutical and pharmaceutical ingredient imports.
Tariffs on Canada, China and Mexico
The White House issued Feb. 1 executive orders that impose tariffs on products from Canada, Mexico and China.